Philip Morris International Inc

About Philip Morris International Inc

Philip Morris International sells cigarettes and smoke-free nicotine products to adult consumers through retailers and distributors. Its established combustible-tobacco business includes cigarette brands, while its smoke-free portfolio includes heated-tobacco products such as IQOS and nicotine pouches such as ZYN. The company makes money from sales across these product lines; the supplied figures do not break out their respective revenue contributions. PMI reports FY2025 revenue of $40.6 billion and net income of $11.3 billion, compared with $37.9 billion and $7.1 billion, respectively, in FY2024.

Notable Price Movement

1. Oct 26-30$208.794.67%

   PM rose $6.76, or 3.35%, from $201.74 on October 22 to $208.50 on October 29. It first fell to $199.47 on October 23, then recovered over the next three sessions, closing at $202.64 on October 28 before jumping $5.86 on Thursday. Argus Research maintained its Buy rating and raised its price target to $220 from $210 on October 26, but the supplied evidence does not establish that this action caused Thursday’s advance. No company-specific news is identified as a catalyst for the late-week jump, and no broader market performance is supplied to explain it.

   13 sources
2. Oct 19-23$199.472.79%

   PM fell $0.95, or 0.47%, from $202.00 on October 12 to $201.05 on October 19. Trading was volatile: shares declined to $199.29 on October 13, rebounded to $205.58 on October 14, fell to $199.90 on October 15, and recovered to $205.20 on October 16 before slipping on October 19. Volume was highest on October 15, at 7.97 million shares, but the supplied evidence does not identify a catalyst tied to that session or to the week’s price action. The Q3 coverage describes an earnings beat alongside concern about guidance, but its timing relative to these closes is not established. No broader-market comparison is supplied, so the weekly move cannot be attributed to market conditions.

   26 sources
3. Oct 12-16$205.201.99%

   Philip Morris shares rose $12.47, or 6.58%, from $189.53 on October 5 to $202.00 on October 12, advancing at each supplied close. The largest move came on October 8, when the stock jumped 4.05% to $200.50; gains continued on October 9 and October 12, with no material reversal. The supplied evidence does not identify a dated company announcement that explains the rally. It does note UBS raised its price target from $182 to $192 and Bank of America reaffirmed its Buy rating, but does not establish when those actions occurred or whether they drove trading. Articles also describe the stock as nearing a 52-week high and flag rising Treasury yields as a potential headwind; no broader market performance data is supplied.

   23 sources
4. Oct 5-9$201.197.32%

   PM fell 1.81%, from $193.90 to $190.40. The dominant move was a selloff from $193.90 on September 29 to $187.46 on October 2, followed by a partial recovery to $189.53 on October 5 and $190.40 on October 6. The supplied evidence does not establish a dated company-specific catalyst for either leg. A Seeking Alpha headline described investors moving into tobacco stocks amid interest-rate anxiety, offering sector context, but the evidence does not show that this drove PM’s daily moves. Another headline reports that Philip Morris raised its per-share outlook, but it is undated relative to the trading window and cannot be tied confidently to the recovery. No broader market performance data is supplied to explain the remaining move.

   20 sources
5. Sep 28 - Oct 2$187.461.59%

   PM fell 1.73%, from $191.50 on September 24 to $188.18 on October 1. The shares rose to $193.76 on Monday and $193.90 on Tuesday, then reversed course, losing ground on Wednesday and Thursday and giving back the early-week advance. The supplied evidence identifies no company-specific announcement or catalyst for the decline. The available context instead points to pressure and uncertainty across consumer staples: Zacks cited falling consumer sentiment, inflation concerns and renewed rate-hike worries, while also describing PM as a defensive holding. That backdrop does not establish a direct cause for PM’s weekly move, and the evidence provides no specific market-index comparison.

   17 sources
6. Sep 21-25$190.480.99%

   PM fell 0.45%, from $191.71 to $190.84, but recovered much of an early-week slide. The stock dropped from $191.71 on September 16 to $187.48 on September 21, then rebounded to $190.84 by September 23; trading volume was notably higher on September 18 and throughout September 21–23 than on September 16–17. The supplied coverage reports an 8.8% dividend increase and discusses the company’s smoke-free strategy, but it does not establish when those developments occurred or connect them to the weekly price action. Nor does the evidence identify a market-wide catalyst. The decline and subsequent rebound therefore lack a substantiated company-specific or broader-market explanation in the available material.

   27 sources
7. Sep 14-18$188.621.28%

   PM rose $12.33, or 6.76%, from $182.53 to $194.86 over the supplied trading sequence. The clearest company-specific catalyst was Philip Morris International’s 8.8% quarterly-dividend increase to $1.60 per share, equivalent to an annualized $6.40, with payment scheduled for October 26 to shareholders of record on October 2. The stock advanced in each listed session, moving from $182.53 on September 4 to $184.73, $185.71, $189.77, $191.06 and finally $194.86 on September 14. Trading volume peaked at 5.32 million shares on September 11 before falling to 2.94 million on September 14. No other company-specific catalyst or material reversal is identified in the supplied evidence.

   25 sources
8. Sep 7-11$191.064.67%

   Philip Morris fell $2.57, or 1.37%, over the reported period, from $187.30 to $184.73. Trading was initially stable, with the stock closing at $187.15 and then rising to $187.94, before declining to $186.17 and $182.53 in the next two sessions. It recovered to $184.73 on the final reported day, although that rebound only partly reversed the earlier drop. Company-specific coverage highlighted FDA clearance and a higher 2026 outlook, including projected adjusted per-share earnings growth of 7.5%-9.5%, but the supplied evidence does not link those developments to particular daily moves. Valuation remained a counterweight, with coverage describing the shares as inexpensive on cash flow but expensive on earnings. No broader market driver is provided.

   28 sources
9. Aug 31 - Sep 4$182.534.88%

   The stock fell $4.31, or 2.26%, from the supplied starting close of $190.48 to $186.17. There was no company-specific announcement in the supplied evidence to explain the decline, so trading appears to have reflected broader market or sector positioning rather than a new fundamental catalyst. PM added $1.41 on August 28 before giving back $4.59 on Monday, August 31. It then edged lower on Tuesday, recovered $0.79 on Wednesday, and declined another $1.77 on Thursday. The pattern was therefore a sharp early-week reversal followed by modest stabilization and renewed selling, while the evidence does not identify a specific market-wide driver.

   18 sources
10. Aug 24-28$191.891.94%

    Philip Morris fell 0.54% over the week, from $191.52 to $190.48. The stock rebounded 1.72% on Monday after the prior Friday’s decline, then added another 1.28% on Tuesday and edged higher Wednesday to $194.10. The early-week strength coincided with coverage of Philip Morris’s manufacturing partnership with Altria, which highlighted potential efficiency benefits, and broader optimism around smoke-free products. Thursday’s 1.86% decline gave back most of the preceding gains, but the supplied evidence identifies no company-specific guidance or other catalyst for that reversal. The week therefore ended modestly lower despite support from ZYN’s FDA authorization and favorable IQOS and ZYN commentary.

    18 sources
11. Aug 17-21$188.231.13%

    PM rose $2.61, or 1.38%, from $188.91 to $191.52 over the week. Trading was volatile: the stock fell 3.1% on Monday to $184.52 on its heaviest volume of the period, then recovered across the next three sessions, gaining 1.7% Tuesday, 1.2% Wednesday and 0.8% Thursday. The rebound followed commentary emphasizing Philip Morris’s earnings beat, guidance support and bullish targets, while an ETF-flow alert also identified PM among stocks with changing fund ownership. No dated company-specific announcement was supplied for the week, so the move appears driven mainly by renewed investor support after Monday’s selloff and favorable earnings-related coverage rather than a new fundamental disclosure.

    23 sources
12. Aug 10-14$190.390.43%

    Philip Morris fell $1.41, or 0.75%, from $187.41 to $186.00 over the period. Trading was uneven: the stock slipped to $186.91 on August 4, rebounded to $188.93 on August 5, eased to $188.05 on August 6, and reached $189.57 on August 7 before giving back the entire advance in the final session. The largest move was the 1.9% decline on August 10, on lighter volume of 3.1 million shares. Available evidence does not identify a company-specific announcement or earnings catalyst explaining the weekly reversal. Coverage continued to focus on the $1.2 billion ZYN investment and smoke-free growth, but the market's direct weekly reaction is not documented.

    18 sources
13. Aug 3-7$189.570.66%

    Philip Morris International fell $13.26, or 6.62%, over the provided trading window, from $200.17 on July 28 to $186.91 on August 4. The decline was orderly but persistent: shares slipped to $198.44 on July 29, dropped to $192.00 on July 30, eased to $190.82 on July 31, then fell to $187.41 and $186.91 on August 3-4. The largest move was the $6.44 drop on July 30, followed by a $3.41 decline on August 3. The supplied evidence identifies no company-specific announcement, earnings update, guidance change, analyst action, or quantified market catalyst explaining the selloff, so the week’s driver remains unresolved.

    3 sources

Stories & Analysis

Can Altria's on! PLUS 12mg Rollout Accelerate Nicotine Pouch Growth?Zacks · 1d agoWant Income for Life? Philip Morris International Yields 3.2% and Has the Kind of Competitive Moat That Makes the Income Durable.The Motley Fool · 5d agoSee Which Recent 13F Filers Hold PMBNK Invest · 6d agoAltria Group Now Yields Twice as Much as Coca-Cola. Is It the Most Overlooked Dividend Stock? Here's the Clear Answer.The Motley Fool · 6d agoInvesco S&P 500 Top 50 ETF Experiences Big InflowBNK Invest · Oct 26Meet the Ultra-High-Yield Dividend Stock That Has Doubled the S&P 500's Returns This YearThe Motley Fool · Oct 25Stock Selloff Continues as Oil SurgesWSJ · Oct 23How Much Do Global Conflicts Change Philip Morris International (PM) Earnings Outlook?Yahoo Finance · Oct 22